And since you mentioned chatgpt here is the response to are iPSC's safe. I didn't bring chatgpt up by the way, so now I guess you will say they are out of date?ChatGPT said:are ipsc's safeGreat question — let’s unpack that carefully.
Induced pluripotent stem cells (iPSCs) are a type of stem cell created by reprogramming adult somatic cells (like skin or blood cells) to revert them into a pluripotent state, meaning they can differentiate into almost any cell type in the body. They’re hugely valuable for research, drug testing, disease modeling, and regenerative medicine.
As for safety — it depends on the context of their use.
Here’s a breakdown:✅ iPSC Safety Positives:
Ethically preferable: No embryos are destroyed to create them.
Patient-specific potential: You can generate iPSCs from a patient’s own cells, minimizing the risk of immune rejection.
Lab research & disease modeling: In vitro uses are considered safe.
⚠️ iPSC Safety Concerns:
Genetic instability: The reprogramming process can introduce genetic mutations or epigenetic abnormalities.
Tumorigenicity: Like embryonic stem cells, iPSCs can form teratomas (benign tumors of mixed tissue) if undifferentiated cells are transplanted.
Reprogramming factors: Traditional methods used viral vectors to introduce genes like c-Myc, which is oncogenic (cancer-promoting). Newer, safer techniques (non-integrating methods like episomal vectors, mRNA, or CRISPR-based systems) reduce this risk but aren’t entirely risk-free.
Incomplete differentiation: If cells aren’t fully or correctly differentiated before transplantation, unintended effects can occur.
Current Status:
In lab and preclinical contexts, they’re widely used and relatively safe.
In clinical trials (there are a handful ongoing globally — e.g., for macular degeneration, Parkinson’s), safety is still being rigorously tested.
Regulatory authorities like the FDA or EMA closely oversee any therapeutic use.
In summary:
✅ Safe in lab research.
⚠️ Potential risks for clinical applications — being actively addressed through better reprogramming, differentiation, and screening techniques.
- Forums
- ASX - By Stock
- Ann: CYP-001s FDA Approval Pathway Not Impeded
CYP
cynata therapeutics limited
Add to My Watchlist
5.56%
!
17.0¢

And since you mentioned chatgpt here is the response to are...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.5¢ | $21.40K | 127.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 425750 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 90178 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 415749 | 0.165 |
7 | 617558 | 0.160 |
2 | 16451 | 0.155 |
3 | 120000 | 0.150 |
2 | 85000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 90178 | 3 |
0.185 | 38745 | 2 |
0.190 | 189688 | 3 |
0.195 | 19300 | 1 |
0.200 | 108000 | 4 |
Last trade - 14.06pm 13/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |